P2.04-46 Tolerability and Treatment-Related Adverse Events of Upfront Pembrolizumab Combination Regimens in Advanced NSCLC Patients
| Autor: | Jahan, N. 1, Thein, K. 2, Sultan, A. 1, Swarup, S. 1, Mogollon-Duffo, F. 1, Adhikari, N. 3, Arevalo, M. 3, Htut, T. 4, Naing, T. 5, D’Cunha, N. 1, Rehman, S. 1, Hardwicke, F. 1, Tijani, L. 1 |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2019 14(10) Supplement:S726-S726 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|